Vascular endothelial cell monolayer formed on membrane filter potentiates the defense against tumor cell invasion by treatment with brefeldin A

Cancer Letters

Volumn 108, Issue 1, 1996, Pages 49-54

  Soeda, Shinji ^a   Honda, Okinobu ^a   Shimeno, Hiroshi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Brefeldin a; Invasion; Plasminogen activator inhibitor 1; Urokinase type plasminogen activator; Vascular endothelial cells

Indexed keywords

BREFELDIN A; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ARTICLE; CANCER INVASION; CELL INVASION; CONTROLLED STUDY; MEMBRANE FILTER; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

BREFELDIN A; CELL ADHESION; CELLS, CULTURED; COLLAGENASES; CYCLOPENTANES; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; NEOPLASM INVASIVENESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TUMOR CELLS, CULTURED; UMBILICAL VEINS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030581605     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04392-3     Document Type: Article

References (13)

1. [1] Danø, K., Andreasen, P.A., Grøndahl-Hansen, J., Kristensen, P., Nielsen, L.S. and Skriver, L. (1985) Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res., 44, 139-266.
2. [2] Laiho, M. and Keski-Oja, J. (1989) Growth factors in the regulation of pericellular proteolysis: a review, Cancer Res., 49, 2533-2553.
3. [3] Cajot, J.F., Bamat, J., Bergozelli, G.E., Kruithof, E.K.O., Medcalf, R.L., Testuz, J. and Sordat, B. (1990) Plasminogen activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells, Proc. Natl. Acad. Sci. USA, 87, 6939-6943.
4. [4] Terranova, V.P., Hujanen, E.S. and Martin, G.R. (1986) Basement membrane and the invasive activity of metastatic tumor cells, J. Natl. Cancer Inst., 77, 311-316.
5. [5] Albini, A., Iwamoto, Y., Kleinman, H.K., Martin, G.R., Aaronson, S.A., Kozlowski, J.M. and McEwan, R.N. (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells, Cancer Res., 47, 3239-3245.
6. [6] Soeda, S., Fujii, N., Shimeno, H. and Nagamatsu, A. (1995) Oversulfated fucoidan and heparin suppress endotoxin induction of plasminogen activator inhibitor-1 in cultured human endofhelial cells: their possible mechanism of action, Biochim. Biophys. Acta, 1269, 85-90.
7. [7] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265-275.
8. [8] Donaldson, J.G., Lippincott-Schwartz, J., Bloom, G.S., Kreis, T.E. and Klausner, R.D. (1990) Dissociation of a 110-kDa peripheral membrane protein from the Golgi apparatus is an early event in brefeldin A action, J. Cell Biol., 111, 2295-2306.
9. [9] Robinson, M.S. and Kreis, T.E. (1992) Recruitment of coat proteins onto Golgi membranes in intact and permeabilized cells: effects of brefeldin A and G protein activators, Cell, 69, 129-138.
10. [10] Fujiwara, T., Oda, K., Yokota, S., Takatsuki, A. and Ikehara, Y. (1988) Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum, J. Biol. Chem., 263, 18545-18552.
11. [11] Soeda, S., Ishida, S., Honda, O., Shimeno, H. and Nagamatsu, A. ( 1994) Aminated fucoidan promotes the invasion of 3 LL cells through reconstituted basement membrane: its possible mechanism of action. Cancer Lett., 85, 133-138.
12. [12] Linardic, C.M., Jayadev, S. and Hannum, Y.A. (1992) Brefeldin A promotes hydrolysis of sphingomyelin, J. Biol. Chem., 267, 14909-14911.
13. [13] Soeda, S., Honda, O., Shimeno, H. and Nagamatsu, A. (1995) Sphingomyelinase and cell-permeable ceramide analogs increase the release of plasminogen activator inhibitor-1 from cultured endothelial cells, Thromb. Res., 80, 509-518.